DTM™ spinal cord stimulation shows superior back pain relief in RCT
By Akshay Kedari  Date: 2020-01-22

DTM™ spinal cord stimulation shows superior back pain relief in RCT

Medtronic plc, a Dublin-based medical technology, services, and solutions company, has reportedly announced three-month results from a large, multicenter RCT (randomized controlled trial) demonstrating statistically meaningful (p=0.0009) and improved back pain relief with DTM (Differential Target Multiplexed) SCS (Spinal Cord Stimulation) compared to conventional SCS. Both arms have used the company’s Intellis™ platform.

Reportedly, the three-month outcomes demonstrated 80% of chronic back pain patients treated with DTM registered minimum 50% pain relief, compared to 51% of the patients treated with conventional SCS, as measured by VAS (Visual Analog Scale).

Meanwhile, the RCT showed great pain relief and substantial reductions in leg and back pain with DTM. 63% of patients with back pain treated with DTM showed great pain relief of 80% or more compared to 26% treated with conventional SCS.

All in all, patients treated with DTM demonstrated an average of 74% decrease in back pain compared to 46% with conventional SCS for three months period. Likewise, improvements were noted with DTM for leg pain with a mean decrease of 72% compared to 59% with conventional SCS.

Matt Thomas, General Manager and Vice President of the Stim and Early Interventions business, that is part of the Restorative Therapies Group at Medtronic, said that DTM therapy is the first customized SCS approach purposely created from new scientific concept and demonstrated in an RCT.

The clinical study determines that DTM therapy offers greater efficacy for chronic back pain patients compared to conventional stimulation. Moreover, when combined with Medtronic Intellis, patients could access superior results as displayed in the RCT on an unrivaled simulation platform.

For a record, Medtronic secured DTM therapy as part of its acquisition of Stimgenics declared in early January. DTM therapy is a new and unique programming option to treat patients who are suffering from chronic pain, and is based on years of preclinical research.

Source Credit - http://newsroom.medtronic.com/news-releases/news-release-details/dtmtm-spinal-cord-stimulation-using-medtronic-intellistm

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Alaskans to use tax credits to aid energy efficiency & air quality
Alaskans to use tax credits to aid energy efficiency & air quality
By Akshay Kedari

Local government authorities in Alaska have reportedly approved a bill that allows the creation and utilization of property tax credit to enhance air quality and energy efficiency. Sources cite that the Senate has accepted the bill with a 17-1 vote a...

Liteye gets $3M production order as part of US Defense Industrial Base
Liteye gets $3M production order as part of US Defense Industrial Base
By Akshay Kedari

Liteye Systems, a renowned leader in CUAS (Counter Unmanned Aerial Systems), has reportedly announced the receipt of an additional specialty production order for approximately $3 million. The contract would further make sure delivery of hardware for ...

Turning Point Brands offers free sanitizer bottles to combat COVID-19
Turning Point Brands offers free sanitizer bottles to combat COVID-19
By Akshay Kedari

From offering medical aids to donating funds, many companies worldwide have come forward to help governments and people to fight the spread of the novel coronavirus. Recently, Turning Point Brands, one of the leading tobacco product manufacturers in ...

Isracann enters JV agreement to develop cannabis production in Israel
Isracann enters JV agreement to develop cannabis production in Israel
By Akshay Kedari

Isracann Biosciences Inc. has recently entered a joint venture agreement for phased partnership of 2 near-term farm operations at the Sharon Plain region in Israel. This JV agreement will provide significant revenue generating opportunities to the Is...

Russia to track people at risk of COVID-19 through their geolocation
Russia to track people at risk of COVID-19 through their geolocation
By Akshay Kedari

Mikhail Mishustin, the Russian Prime Minister, recently gave the regional authorities 5 days for developing a system that can track citizens by using mobile phone geolocation data. The move is aimed at tracking people who have come into contact with ...